U.S. Pumps $3.2 Billion Into Covid-Fighting Antiviral Effort (1)

June 17, 2021, 5:54 PM

The U.S. is investing $3.2 billion into developing antiviral medicines to combat Covid-19 and other viruses with pandemic potential. The aim: develop treatments to be taken at home soon after someone gets sick.

Dubbed the Antiviral Program for Pandemics, the effort led by U.S. health agencies will support the discovery, development and production of antiviral treatments for Covid-19 and future viral threats, the Health and Human Services Department said Thursday.

Though vaccines are significantly slowing the spread of Covid in wealthy nations, doctors around the world need treatments that can be quickly and easily deployed to those who get sick ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.